New ‘guidelines’ for treatment of hypertension has pushed blood pressure targets to 150/90 rather than 140/90, in adults over age 60. According to an estimate coming out of Duke University, this could cause 25% (6 million) those on blood pressure drugs to stop taking their meds.
Pharmer sees this as part of the Obamacare cost cutting pattern. Note that the standards of “need” for mammography, colonoscopy, and various other health measures have recently been downgraded.
One wonders if the pharmaceutical and medical supply companies were forewarned that many of their products and services would no longer be needed with the roll out of Obamacare and the upcoming single-payer plan.